Article

Pathophysiological subtypes of Alzheimer’s disease based on cerebrospinal fluid proteomics

2020-03-27

Abstract excerpt

Alzheimer’s disease (AD) is biologically heterogeneous, and detailed understanding of the processes involved in patients is critical for development of treatments. Cerebrospinal fluid (CSF) contains hundreds of proteins, with concentrations reflecting ongoing (patho)physiological processes. This provides the opportunity to study many biological processes at the same time in patients. We studied whether AD biologic...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 221fe0d4-5e91-5ff0-be93-54103c7dcc37
DOI: 10.1101/2020.03.25.20043158

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Pathophysiological subtypes of Alzheimer’s disease based on cerebrospinal fluid proteomicsDOI 10.1101/2020.03.25.20043158Read

Pathophysiological subtypes of Alzheimer’s disease based on cerebrospinal fluid proteomicsSemantic proximity Read

Large-scale cerebrospinal fluid proteomic analysis in Alzheimer’s disease patients reveals five molecular subtypes with distinct genetic risk profilesSemantic proximity Read

Cerebrospinal fluid proteomics in patients with Alzheimer’s disease reveals five molecular subtypes with distinct genetic risk profilesSemantic proximity Read

Proteomic Subtyping of Alzheimer’s Disease CSF links Blood-Brain Barrier Dysfunction to Reduced levels of Tau and Synaptic BiomarkersSemantic proximity Read

Cerebrospinal fluid proteomics and biological heterogeneity in Alzheimer’s disease: A literature reviewSemantic proximity Read

Multi-cohort cerebrospinal fluid proteomics identifies robust molecular signatures across the Alzheimer disease continuumSemantic proximity Read

Molecular subtyping of Alzheimer's disease with consensus non-negative matrix factorization.Semantic proximity Read

CSF proteomics identifies early changes in autosomal dominant Alzheimer's disease.Semantic proximity Read

CSF proteome profiling across the Alzheimer’s disease spectrum reflects the multifactorial nature of the disease and identifies specific biomarker panelsSemantic proximity Read

Proteomics of brain, CSF, and plasma identifies molecular signatures for distinguishing sporadic and genetic Alzheimer’s diseaseSemantic proximity Read

Proteomic Signatures of Neuropathological Alterations in Alzheimer’s Disease: Insights from the Bio-Hermes StudySemantic proximity Read

Multiplex proteomics identifies novel CSF and plasma biomarkers of early Alzheimer’s diseaseSemantic proximity Read